Medical Procedure News

RSS

Integra launches second size of Endoscopic Gastroc Release System

Integra LifeSciences Holdings Corporation announced today the launch of a second size of the Integra™ Endoscopic Gastroc Release (EGR) System in the United States. Integra's EGR System is a disposable device with a unique articulating blade that allows selective cutting of soft tissues. It is intended for use in the surgical treatment for posterior heel cord, or equinus, contracture.

14 Dec 2010

Chinese hospital uses UNIQUE radiotherapy system to treat cancer patients

Prince of Wales Hospital in Hong Kong, China, has become the first treatment center in Asia to commence treating cancer patients using the UNIQUE™ medical linear accelerator from Varian Medical Systems (NYSE: VAR).

14 Dec 2010

Gore releases statement in response to safety of GORE HELEX Septal Occluder for PFO closure in cryptogenic stroke patients

W. L. Gore & Associates (Gore) today released the following statement from the Gore REDUCE Clinical Study Principal Investigators on behalf of the Gore REDUCE Clinical Study Steering Committee in response to the recent CLOSURE I results presentation.

14 Dec 2010

Study finds carotid artery stenting has higher risk of stroke and death than carotid endarterectomy

To meet reimbursement criteria, candidates for carotid artery stenting (CAS) must either be high-risk surgical patients or be enrolled in a critical trial.

14 Dec 2010

Capstone presents AZX100 Phase 2a trial results for keloid and trocar site scarring

Capstone Therapeutics announced today twelve-month results from its two AZX100 Phase 2a pilot clinical trials in keloid scarring and seven-month interim results of its ongoing AZX100 Phase 2a pilot clinical trial in surgical (trocar site) scarring.

14 Dec 2010

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental New Drug Application (sNDA) for DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension for use in stress echocardiography.

14 Dec 2010

Enrollment commences in multi-center clinical trial of CorMatrix ECM for Pericardial Closure

CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that Franciscan Alliance/St. Francis Heart Center in Indianapolis, Indiana is the first site to enroll a patient in the multi-center clinical trial of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation.

13 Dec 2010

FDA clears Clear Catheter Systems' PleuraFlow Active Tube Clearance System

Clear Catheter Systems, Inc., a Bend, Oregon-based medical device company, announced today that it has received US Food and Drug Administration clearance for its innovative PleuraFlow™ Active Tube Clearance System. This is a device that can be widely deployed in the post operative management of patients requiring heart and lung surgery.

13 Dec 2010

South Korean FDA approves EDAP's new Sonolith i-move lithotripter

EDAP TMS SA, the global leader in therapeutic ultrasound, reported today the approval of its new lithotripter Sonolith i-move by South-Korean Food and Drug Administration (KFDA).

13 Dec 2010

Ascension Orthopedics reports first implantation of PyroTITAN Humeral Resurfacing Implant in France

Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Implant in France. The PyroTITAN was implanted in a 68-year-old patient suffering from painful primary arthritis with synovial osteochondromotosis at Imperial Park Clinic in Nice – making it a surgical first in continental Europe. The patient was discharged from the hospital the next day and reported good pain relief 10 days after surgery.

13 Dec 2010

GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.

13 Dec 2010

Researchers examine outcomes related to antiplatelet therapy in patients undergoing CEA

Despite the common clinical practice among surgeons to discontinue their patients' anti-platelet therapy prior to surgery, a recent study of patients undergoing carotid endarterectomy (CEA) indicated that this practice may be unnecessary.

13 Dec 2010

HRSA ranks UCLA's heart transplant program as best in the U.S.

A new survey by an agency of the U.S. Department of Health and Human Resources has recognized the heart transplant program at Ronald Reagan UCLA Medical Center as the nation's best.

13 Dec 2010

Higher co-payments lead to early discontinuation of life-saving therapy for breast cancer

A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early stage breast cancer.

13 Dec 2010

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy. Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health's Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic Oncology (SUO) annual meeting.

13 Dec 2010

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to researchers from the University of Texas MD Anderson Cancer Center.

13 Dec 2010

Study shows stereotactic radiation therapy as effective as surgery in elderly patients with early-stage lung cancer

A new study shows that a new type of targeted radiation therapy called stereotactic radiation therapy is just as good as surgery for patients aged 75 and older with early-stage lung cancer, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago.

13 Dec 2010

New York City surgeon performs first revision rhinoplasty cases with FDA approved PDS Plate

Today Dr. Steven Pearlman, prominent facial plastic and reconstructive surgeon based in New York City, will be performing one of the first revision rhinoplasty cases with the newly FDA approved PDS Plate. This revolutionary procedure will mark a giant leap in the world of cosmetic and reconstructive surgery.

13 Dec 2010

Cesarean-section deliveries may lead to degenerative back disease

Researchers from Michigan State University are studying whether pregnancies, specifically cesarean-section deliveries, are linked to a degenerative back disease that affects women three to nine times more often than men.

13 Dec 2010

High CTC level found to be early marker of poor outcome in metastatic breast cancer

A high level of circulating tumor cells (CTCs) - cells that have detached from a tumor and are circulating in the body through the blood - are an independent prognostic marker in metastatic breast cancer as first-line therapy.

13 Dec 2010

Medical Procedure News

Integra launches second size of Endoscopic Gastroc Release System

Chinese hospital uses UNIQUE radiotherapy system to treat cancer patients

Gore releases statement in response to safety of GORE HELEX Septal Occluder for PFO closure in cryptogenic stroke patients

Study finds carotid artery stenting has higher risk of stroke and death than carotid endarterectomy

Capstone presents AZX100 Phase 2a trial results for keloid and trocar site scarring

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

Enrollment commences in multi-center clinical trial of CorMatrix ECM for Pericardial Closure

FDA clears Clear Catheter Systems' PleuraFlow Active Tube Clearance System

South Korean FDA approves EDAP's new Sonolith i-move lithotripter

Ascension Orthopedics reports first implantation of PyroTITAN Humeral Resurfacing Implant in France

GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

Researchers examine outcomes related to antiplatelet therapy in patients undergoing CEA

HRSA ranks UCLA's heart transplant program as best in the U.S.

Higher co-payments lead to early discontinuation of life-saving therapy for breast cancer

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

Study shows stereotactic radiation therapy as effective as surgery in elderly patients with early-stage lung cancer

New York City surgeon performs first revision rhinoplasty cases with FDA approved PDS Plate

Cesarean-section deliveries may lead to degenerative back disease

High CTC level found to be early marker of poor outcome in metastatic breast cancer

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News